EUVIMEDEUVIMED entdecken
Open Access

A trafficking regulatory subnetwork governs α V β 6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance

Horacio Maldonado iD, Marcel Dreger iD, Lara D Bedgood, Theano Kyriakou iD, Katarzyna I Wolanska iD, Megan E Rigby iD, Valeria E Marotta iD, Justine M Webster, Jun Wang iD, Emma V Rusilowicz-Jones iD, John F Marshall, Judy M Coulson iD und 3 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.adk9944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Horacio Maldonado und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 3BX, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Erb-b2 Receptor Tyrosine Kinases, Integrins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HER2 and α V β 6 integrin are independent predictors of breast cancer survival and metastasis. We identify an α V β 6 /HER2 cross-talk mechanism driving invasion, which is dysregulated in drug-resistant HER2+ breast cancer cells. Proteomic analyses reveal ligand-bound α V β 6 recruits HER2 and a trafficking subnetwork, comprising guanosine triphosphatases RAB5 and RAB7A and the Rab regulator guanine nucleotide dissociation inhibitor 2 (GDI2). The RAB5/RAB7A/GDI2 functional module mediates direct cross-talk between α V β 6 and HER2, affecting receptor trafficking and signaling. Acute exposure to trastuzumab increases recruitment of the subnetwork to α V β 6 , but trastuzumab resistance decouples GDI2 recruitment. GDI2, RAB5, and RAB7A cooperate to regulate migration and transforming growth factor–β activation to promote invasion. However, these mechanisms are dysregulated in trastuzumab-resistant cells. In patients, RAB5A , RAB7A , and GDI2 expression correlates with patient survival and α V β 6 expression predicts relapse following trastuzumab treatment. Thus, the RAB5/RAB7A/GDI2 subnetwork regulates α V β 6 -HER2 cross-talk to drive breast cancer invasion but is subverted in trastuzumab-resistant cells to drive α V β 6 -independent and HER2-independent tumor progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug Resistance, NeoplasmErb-b2 Receptor Tyrosine KinasesIntegrinsrab GTP-Binding ProteinsTrastuzumabrab5 GTP-Binding Proteinsrab7 GTP-Binding ProteinsHumansFemaleCell Line, TumorNeoplasm InvasivenessProtein TransportCell MovementSignal TransductionAnimalsMiceAntigens, Neoplasm

Substanzen

Erb-b2 Receptor Tyrosine KinasesIntegrinsrab GTP-Binding ProteinsTrastuzumabrab5 GTP-Binding Proteinsrab7 GTP-Binding ProteinsAntigens, Neoplasmintegrin alphavbeta6ERBB2 protein, humanRAB5C protein, human

Autor:innen und Institutionen

  • Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
  • Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine & Health, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
  • Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK.
  • Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow G61 1QH, UK.

ORCID-Profile: Horacio Maldonado, Marcel Dreger, Theano Kyriakou, Katarzyna I Wolanska, Megan E Rigby, Valeria E Marotta, Jun Wang, Emma V Rusilowicz-Jones, Judy M Coulson, Iain R Macpherson, Adam Hurlstone, Mark R Morgan

Zitieren

APA

Maldonado, H., Dreger, M., Bedgood, L. D., Kyriakou, T., Wolanska, K. I., Rigby, M. E., Marotta, V. E., Webster, J. M., Wang, J., Rusilowicz-Jones, E. V., Marshall, J. F., Coulson, J. M., Macpherson, I. R., Hurlstone, A., & Morgan, M. R. (2024). A trafficking regulatory subnetwork governs α V β 6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance. Science Advances. https://doi.org/10.1126/sciadv.adk9944

Vancouver

Maldonado H, Dreger M, Bedgood LD, Kyriakou T, Wolanska KI, Rigby ME, et al. A trafficking regulatory subnetwork governs α V β 6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance. Science Advances. 2024. doi:10.1126/sciadv.adk9944

BibTeX
@article{Maldonado2024,
  author = {Maldonado, Horacio and Dreger, Marcel and Bedgood, Lara D and Kyriakou, Theano and Wolanska, Katarzyna I and Rigby, Megan E and Marotta, Valeria E and Webster, Justine M and Wang, Jun and Rusilowicz-Jones, Emma V and Marshall, John F and Coulson, Judy M and Macpherson, Iain R and Hurlstone, Adam and Morgan, Mark R},
  title = {A trafficking regulatory subnetwork governs α V β 6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adk9944}
}
Kostenlos starten →